A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases – data from nationwide registries in Finland

References

• Filipowicz-Sosnowska AM, Rostopowicz-Denisiewicz K, Rosentahl CJ, Baum J. The amyloidosis of juvenile rheumatoid arthritis – comparative studies in Polish and American children. I. Levels of serum SAA protein. Arthritis Rheum 1978;21:699–703.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996;35:44–49.
   PubMedGoogle Scholar
• Kvalvik AG. Mortality in rheumatoid arthritis. Rheumatol Eur 1996;25:9–14.
   Google Scholar
• Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M. Amyloidosis in a nationwide-series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology 1999;38:499–503.
   PubMed Web of Science ®Google Scholar
• Savolainen HA, Isomäki HA. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993;20:1201–1203.
   PubMed Web of Science ®Google Scholar
• Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174–176.
   PubMed Web of Science ®Google Scholar
• Sihvonen S, Korpela M, Mustonen J, Laippala P, Pasternack A. Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 2004;96:107–114.
   PubMedGoogle Scholar
• Immonen K, Savolainen A, Kautiainen H, Hakala M. Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis. J Rheumatol 2008;35:907–912.
   PubMed Web of Science ®Google Scholar
• Kuroda T, Tanabe N, Harada T, Murakami S, Hasegawa H, Sakatsume M, Nakano M, Geiyo F. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol 2005;25:498–505.
   PubMed Web of Science ®Google Scholar
• Potyšová Z, Merta M, Tesař V, Jančová E, Honsová E, Ryšavá R. Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre. Int Urol Nephrol 2009;41:941–945.
   PubMed Web of Science ®Google Scholar
• Hazenberg BPC, van Rijswijk MH. Where has secondary amyloidosis gone? Ann Rheum Dis 2000;59:577–579.
   PubMed Web of Science ®Google Scholar
• Immonen K, Finne P, Hakala M, Kautiainen H, Pettersson T, Grönhagen-Riska C. No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases – data from the Finnish national registry for kidney diseases. J Rheumatol 2008;35:1334–1338.
   PubMed Web of Science ®Google Scholar
• Finne P, Reunanen A, Stenman S, Groop P-H, Grönhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005;14:1782–1787.
   Google Scholar
• Finnish Registry for Kidney Diseases Report 2008. Helsinki, Finland: Finnish Kidney Diseases; 2009. Available at: http://www.musili.fi/smtr/englishAccessed January 12, 2011..
   Google Scholar
• Laiho K, Tiitinen S, Kaarela K, Helin H, Isomäki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 1999;18:122–123.
   PubMed Web of Science ®Google Scholar
• Möttönen T, Hannonen P, Leirisalo-Repo M, Nissila M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999;353:1568–1573.
   PubMed Web of Science ®Google Scholar
• Sokka T, Hetland ML, Mäkinen H, Kautiainen H, Hørslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, et al. Remission and rheumatoid arthritis: Data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008;58:2642–2651.
   PubMed Web of Science ®Google Scholar
• Tiitinen S, Myllykangas R, Helin H, Kaarela K. Modern trends in the diagnosis of secondary amyloidosis. Scand J Rheumatol Suppl 1988;67:30–31.
   Google Scholar
• Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, Combe B, Durbach A, Sibilia J, Dougados M, et al. Anti-tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a follow up report of tolerability and efficacy. Arhritis Rheum 2003;48:2019–2024.
   PubMed Web of Science ®Google Scholar
• Falck HM, Maury CPJ, Teppo A-M, Wegelius O. Correlation of persistently high serum amyloid A and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J 1983;286:1391–1393.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24–29.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Goodman HJB, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic amyloidosis. N Engl J Med 2007;356:2361–2371.
   PubMed Web of Science ®Google Scholar
• Uda H, Yokota A, Kobayashi K, Miyake T, Fushimi H, Maeda A, Saiki O. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis. J Rheumatol 2006;33:1482–1487.
   PubMed Web of Science ®Google Scholar
• Koivuniemi R, Paimela L, Suomalainen R, Törnroth T, Leirisalo-Repo M. Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid 2008;15:262–268.
   PubMed Web of Science ®Google Scholar